P021 Prognostic significance of beta 2 microglobulin predicting survival in patients with myelodysplastic syndromes
- 作者A. Galanopoulos; D. Gogos; A. Aggelidis; S. Papanikolaou; A. Argyrou; T. Marinakis; E. Michalis; G. Gortzolidis; V. Grigoraki; E. Griva-Kritikou; N. Anagnostopoulos
- 卷第33卷
- 印刷ISSN0145-2126
- 文件大小41.03KB
- 发表时间2009
- DOI10.1016/s0145-2126(09)70101-8
P-36 Trisomy 8 alone in myelodysplasticsyndromes: Recognition of the common clinico-hematologic features from 109 patientsA.S. Symeonidis; T. Marinakis; H. Papadakis; A. Kouraklis; A. Galanopoulos; P. Roussou; E. Terpos; N.A. Viniou; S. Polyclronopoulou; C. Tsatalas; N. Zoumbos · 2005
P-15 Chronic myelomonocytic leukemia:IPSS best discriminates patients with worse prognosis, in both the dysplastic and the proliferative subtypeA.S. Symeonidis; V. Lambropoulou; E. Michalis; A. Chatzivassilis; A. Kouraklis; A. Galanopoulos; P. Matsouka; N. Anagnostopoulos; P. Iliakis; N. Zoumbos · 2005
P-16 Determination of the response toanemia index (RAI) in patients with MDS. Recognition of this parameter as a major predictor of in vivo response to treatment with rh-EPOA.S. Symeonidis; M. Leotsinidis; A. Kouraklis; N. Zoumbos · 2005